Peptide Therapeutics Market (Application: Cancer, Metabolic, CVD, Respiratory, GIT, Anti-infective, Dermatology, CNS, and Renal) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031

Publish Date: Oct 2022

Report Code: TMR3415A

Publisher: Transparency

Single User License: $5795

Explore Our Services

Already a member? Login here.

Report Highlights

Peptide Therapeutics Market – Scope of Report

TMR’s report on the global peptide therapeutics market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2022 to 2031. The report provides revenue of the global peptide therapeutics market for the period 2017–2031, considering 2021 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global peptide therapeutics market from 2022 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the peptide therapeutics market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global peptide therapeutics market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the global peptide therapeutics market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global peptide therapeutics market.

The report delves into the competitive landscape of the global peptide therapeutics market. Key players operating in the global peptide therapeutics market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global peptide therapeutics market profiled in this report.

RESEARCH METHODOLOGY

The research methodology will be a combination of exhaustive primary and secondary research to analyze the market peptide therapeutics.

Secondary Research

Secondary research includes a search of company literature, technical writing, patent data, Internet sources, and statistical data from government websites, trade associations, and agencies. This has proven to be the most reliable, effective, and successful approach for obtaining precise data, capturing industry participants’ insights, and recognizing business opportunities.

Secondary research sources that we typically refer, but are not limited to:

  • Company websites, presentations, annual reports, white papers, technical paper, product brochure
  • Internal and external proprietary databases and relevant patents
  • National government documents, statistical databases, and market reports
  • News articles, press releases, and webcasts specific to companies operating in the market

Specific Secondary Sources:

  • Industry Sources:
  • WorldWideScience.org
  • Elsevier, Inc.
  • National Institutes of Health (NIH)
  • PubMed
  • NCBI
  • Department of Health Care Service
  • Trade Data Sources
  • Trade Map
  • UN Comtrade
  • Trade Atlas
  • Company Information
  • OneSource Business Browser
  • Hoover’s
  • Factiva
  • Bloomberg
  • Mergers & Acquisitions
  • Thomson Mergers & Acquisitions
  • MergerStat
  • Profound

Primary Research

During the course of research, we conduct in-depth interviews and discussions with a wide range of key industry participants and opinion leaders. Primary research represents bulk of research efforts, supplemented by extensive secondary research.

We conduct primary interviews on the ongoing basis with industry participants and commentators to validate data and analysis. A typical research interview fulfills the following functions:

  • Provides first-hand information on market size, market trends, growth trends, competitive landscape, outlook, etc.
  • Helps in validating and strengthening secondary research findings
  • Further develops the analysis team’s expertise and market understanding
  • Primary research involves e-mail interactions, telephonic interviews, as well as face-to-face interviews for each market, category, segment, and sub-segment across geographies

Participants who typically take part in such a process include, but are not limited to:

  • Industry participants: Marketing/product managers, market intelligence managers, and regional sales managers
  • Purchasing/Sourcing managers, technical personnel, distributors
  • Outside experts: Investment bankers, valuation experts, and research analysts specializing in specific markets
  • Key opinion leaders specializing in different areas corresponding to different industry verticals

List of primary participants, but not limited to:

  • Advanced Oncotherapy PLC
  • Danfysik A/S
  • Hitachi, Ltd.
  • IBA Worldwide
  • Mevion Medical Systems, Inc.

Report Synopsis

Report Metrics Details
Base year considered 2022
Forecast period considered 2022-2031
Growth rate 8.80%
Units considered $ Million
Segments covered By Route of Administration, By Technology, By Type, By Application, By Region
Industry covered Pharmaceutical
Countries covered North America, Europe, Asia Pacific, Middle East & Africa, Latin America
Companies studied
  • Amgen, Inc.,
  • F. Hoffmann-La Roche Ltd.,
  • Bachem Holding AG,
  • Eli Lilly and Company,
  • Teva Pharmaceutical Industries Ltd.
  • GlaxoSmithKline plc,
  • Novartis AG,Pfizer, Inc.,
  • Sanofi,
  • Takeda Pharmaceutical Company Limited,

Data Triangulation: Information culled from “Secondary & Primary Sources” is cross-checked with “TMR Knowledge Repository”, which is updated every quarter.

Market Estimation: Market size estimations involved in-depth study of product features, technology updates, geographic presence, product demand, sales data (value or volume), historical year-on-year growth, and others. Other approaches were also utilized to derive market size and forecasts. Where no hard data was available, we employed modeling techniques in order to produce comprehensive datasets. A rigorous methodology has been adopted, wherein the available hard data are cross-referenced with the following data types to produce estimates:

Demographic Data: Healthcare expenditure, inflation rates, and others

Industry Indicators: R&D investment, technology stage, and infrastructure, sector growth, and facilities

Market Forecasting: Market forecasts for various segments are derived taking into account drivers, restraints/challenges, and opportunities prevailing in the market and considering advantages/disadvantages of segments/sub-segments over other segments/sub-segments. Business environment, historical sales pattern, unmet needs, competitive intensity, and country-wise surgery data are some of the other pivotal factors, which are considered to derive market forecasts.

  • Table 1 : Global Peptide Therapeutics Market Size (US$ Mn) Forecast, by Application, 2021–2031
  • Table 2 : Global Peptide Therapeutics Market Size (US$ Mn) Forecast, by Route of Administration, 2021–2031
  • Table 3 : Global Peptide Therapeutics Market Size (US$ Mn) Forecast, by Type, 2021–2031
  • Table 4 : Global Peptide Therapeutics Market Size (US$ Mn) Forecast, by Technology, 2021–2031
  • Table 5 : Global Peptide Therapeutics Market Size (US$ Mn) Forecast, by Type of Molecule, 2021–2031
  • Table 6 : Global API Peptide Therapeutics Market Size (US$ Mn) Forecast, by Type, 2021–2031
  • Table 7 : Global Peptide Therapeutics Market Size (US$ Mn) Forecast, by Region, 2021–2031
  • Table 8 : North America Peptide Therapeutics Market Size (US$ Mn) Forecast, by Country, 2021–2031
  • Table 9 : North America Peptide Therapeutics Market Size (US$ Mn) Forecast, by Application, 2021–2031
  • Table 10 : North America Peptide Therapeutics Market Size (US$) Forecast, by Route of Administration, 2021–2031
  • Table 11 : North America Peptide Therapeutics Market Size (US$ Mn) Forecast, by Type, 2021–2031
  • Table 12 : North America Peptide Therapeutics Market Size (US$ Mn) Forecast, by Technology, 2021–2031
  • Table 13 : North America Peptide Therapeutics Market Size (US$ Mn) Forecast, by Type of Molecule, 2021–2031
  • Table 14 : North America API Peptide Therapeutics Market Size (US$ Mn) Forecast, by Type, 2021–2031
  • Table 15 : Europe Peptide Therapeutics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2021–2031
  • Table 16 : Europe Peptide Therapeutics Market Size (US$ Mn) Forecast, by Application, 2021–2031
  • Table 17 : Europe Peptide Therapeutics Market Size (US$) Forecast, by Route of Administration, 2021–2031
  • Table 18 : Europe Peptide Therapeutics Market Size (US$ Mn) Forecast, by Type, 2021–2031
  • Table 19 : Europe Peptide Therapeutics Market Size (US$ Mn) Forecast, by Technology, 2021–2031
  • Table 20 : Europe Peptide Therapeutics Market Size (US$ Mn) Forecast, by Type of Molecule, 2021–2031
  • Table 21 : Europe API Peptide Therapeutics Market Size (US$ Mn) Forecast, by Type, 2021–2031
  • Table 22 : Asia Pacific Peptide Therapeutics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2021–2031
  • Table 23 : Asia Pacific Peptide Therapeutics Market Size (US$ Mn) Forecast, by Application, 2021–2031
  • Table 24 : Asia Pacific Peptide Therapeutics Market Size (US$) Forecast, by Route of Administration, 2021–2031
  • Table 25 : Asia Pacific Peptide Therapeutics Market Size (US$ Mn) Forecast, by Type, 2021–2031
  • Table 26 : Asia Pacific Peptide Therapeutics Market Size (US$ Mn) Forecast, by Technology, 2021–2031
  • Table 27 : Asia Pacific Peptide Therapeutics Market Size (US$ Mn) Forecast, by Type of Molecule, 2021–2031
  • Table 28 : Asia Pacific API Peptide Therapeutics Market Size (US$ Mn) Forecast, by Type, 2021–2031
  • Table 29 : Latin America Peptide Therapeutics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2021–2031
  • Table 30 : Latin America Peptide Therapeutics Market Size (US$ Mn) Forecast, by Application, 2021–2031
  • Table 31 : Latin America Peptide Therapeutics Market Size (US$) Forecast, by Route of Administration, 2021–2031
  • Table 32 : Latin America Peptide Therapeutics Market Size (US$ Mn) Forecast, by Type, 2021–2031
  • Table 33 : Latin America Peptide Therapeutics Market Size (US$ Mn) Forecast, by Technology, 2021–2031
  • Table 34 : Latin America Peptide Therapeutics Market Size (US$ Mn) Forecast, by Type of Molecule, 2021–2031
  • Table 35 : Latin America API Peptide Therapeutics Market Size (US$ Mn) Forecast, by Type, 2021–2031
  • Table 36 : Middle East & Africa Peptide Therapeutics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2021–2031
  • Table 37 : Middle East & Africa Peptide Therapeutics Market Size (US$ Mn) Forecast, by Application, 2021–2031
  • Table 38 : Middle East & Africa Peptide Therapeutics Market Size (US$) Forecast, by Route of Administration, 2021–2031
  • Table 39 : Middle East & Africa Peptide Therapeutics Market Size (US$ Mn) Forecast, by Type, 2021–2031
  • Table 40 : Middle East & Africa Peptide Therapeutics Market Size (US$ Mn) Forecast, by Technology, 2021–2031
  • Table 41 : Middle East & Africa Peptide Therapeutics Market Size (US$ Mn) Forecast, by Type of Molecule, 2021–2031
  • Table 42 : Middle East & Africa API Peptide Therapeutics Market Size (US$ Mn) Forecast, by Type, 2021–2031
  • Figure 1 : Global Peptide Therapeutics Market Value Share Analysis, by Application, 2021 and 2031
  • Figure 2 : Global Cancer Peptide Therapeutics Market Size Forecast (US$ Mn), 2021–2031
  • Figure 3 : Global Metabolic Peptide Therapeutics Market Size Forecast (US$ Mn), 2021–2031
  • Figure 4 : Global CVD Peptide Therapeutics Market Size Forecast (US$ Mn), 2021–2031
  • Figure 5 : Global Respiratory Peptide Therapeutics Market Size Forecast (US$ Mn), 2021–2031
  • Figure 6 : Global GIT Peptide Therapeutics Market Size Forecast (US$ Mn), 2021–2031
  • Figure 7 : Global Anti-infective Peptide Therapeutics Market Size Forecast (US$ Mn), 2021–2031
  • Figure 8 : Global Dermatology Peptide Therapeutics Market Size Forecast (US$ Mn), 2021–2031
  • Figure 9 : Global CNS Peptide Therapeutics Market Size Forecast (US$ Mn), 2021–2031
  • Figure 10 : Global Renal Peptide Therapeutics Market Size Forecast (US$ Mn), 2021–2031
  • Figure 11 : Global Others Peptide Therapeutics Market Size Forecast (US$ Mn), 2021–2031
  • Figure 12 : Global Peptide Therapeutics Market Attractiveness Analysis, by Application, 2022–2031
  • Figure 13 : Global Peptide Therapeutics Market Value Share Analysis, by Route of Administration, 2021 and 2031
  • Figure 14 : Global Peptide Therapeutics Market Size (US$ Mn) Forecast, by Parenteral, 2021–2031
  • Figure 15 : Global Peptide Therapeutics Market Size (US$ Mn) Forecast, by Oral, 2021–2031
  • Figure 16 : Global Peptide Therapeutics Market Size (US$ Mn) Forecast, by Others, 2021–2031
  • Figure 17 : Global Peptide Therapeutics Market Attractiveness Analysis, by Route of Administration, 2022–2031
  • Figure 18 : Global Peptide Therapeutics Market Value Share Analysis, by Type, 2021 and 2031
  • Figure 19 : Global Innovative Peptide Therapeutics Market Size (US$ Mn), 2021–2031
  • Figure 20 : Global Generic Peptide Therapeutics Market Size (US$ Mn), 2021–2031
  • Figure 21 : Global Peptide Therapeutics Market Attractiveness Analysis, by Type, 2022–2031
  • Figure 22 : Global Peptide Therapeutics Market Value Share Analysis, by Technology, 2021 and 2031
  • Figure 23 : Global Liquid Phase Peptide Therapeutics Market Size Forecast (US$ Mn), 2021–2031
  • Figure 24 : Global Solid Phase Peptide Therapeutics Market Size Forecast (US$ Mn), 2021–2031
  • Figure 25 : Global Hybrid Phase Peptide Therapeutics Market Size Forecast (US$ Mn), 2021–2031
  • Figure 26 : Global Peptide Therapeutics Market Attractiveness Analysis, by Technology, 2022–2031
  • Figure 27 : Global Peptide Therapeutics Market Value Share Analysis, by Type of Molecules, 2021 and 2031
  • Figure 28 : Global Vasopressin Peptide Therapeutics Market Size Forecast (US$ Mn), 2021–2031
  • Figure 29 : Global Somatostatins Peptide Therapeutics Market Size Forecast (US$ Mn), 2021–2031
  • Figure 30 : Global Calcitonin Peptide Therapeutics Market Size Forecast (US$ Mn), 2021–2031
  • Figure 31 : Global Immunopeptides Therapeutics Market Size Forecast (US$ Mn), 2021–2031
  • Figure 32 : Global Natriuretic Peptide Therapeutics Market Size Forecast (US$ Mn), 2021–2031
  • Figure 33 : Global Other Peptides Therapeutics Market Size Forecast (US$ Mn), 2021–2031
  • Figure 34 : Global Peptide Therapeutics Market Attractiveness Analysis, by Type of Molecule, 2022–2031
  • Figure 35 : Global API Peptide Therapeutics Market Value Share Analysis, by Type, 2021 and 2031
  • Figure 36 : Global In-house Peptide Therapeutics Market Size Forecast (US$ Mn), 2021–2031
  • Figure 37 : Global CMO Peptide Therapeutics Market Size Forecast (US$ Mn), 2021–2031
  • Figure 38 : Global API Peptide Therapeutics Market Attractiveness Analysis, by Type, 2022–2031
  • Figure 39 : North America Peptide Therapeutics Market Size (US$ Mn) Forecast, 2021–2031
  • Figure 40 : Europe Peptide Therapeutics Market Size (US$ Mn) Forecast, 2021–2031
  • Figure 41 : Asia Pacific Peptide Therapeutics Market Size (US$ Mn) Forecast, 2021–2031
  • Figure 42 : Latin America Peptide Therapeutics Market Size (US$ Mn) Forecast, 2021–2031
  • Figure 43 : MEA Peptide Therapeutics Market Size (US$ Mn) Forecast, 2021–2031
  • Figure 44 : Global Peptide Therapeutics Market Attractiveness Analysis, by Region, 2022–2031
  • Figure 45 : U.S. Peptide Therapeutics Market Size (US$ Mn) Forecast, 2021–2031
  • Figure 46 : Canada Peptide Therapeutics Market Size (US$ Mn) Forecast, 2021–2031
  • Figure 47 : North America Peptide Therapeutics Market Attractiveness Analysis, by Country, 2022–2031
  • Figure 48 : North America Peptide Therapeutics Market Attractiveness Analysis, by Route of Administration, 2022–2031
  • Figure 49 : North America Peptide Therapeutics Market Attractiveness Analysis, by Type, 2022–2031
  • Figure 50 : North America Peptide Therapeutics Market Attractiveness Analysis, by Technology, 2022–2031
  • Figure 51 : Germany Peptide Therapeutics Market Size (US$ Mn) Forecast, 2021–2031
  • Figure 52 : U.K. Peptide Therapeutics Market Size (US$ Mn) Forecast, 2021–2031
  • Figure 53 : France Peptide Therapeutics Market Size (US$ Mn) Forecast, 2021–2031
  • Figure 54 : Italy Peptide Therapeutics Market Size (US$ Mn) Forecast, 2021–2031
  • Figure 55 : Spain Peptide Therapeutics Market Size (US$ Mn) Forecast, 2021–2031
  • Figure 56 : Rest of Europe Peptide Therapeutics Market Size (US$ Mn) Forecast, 2021–2031
  • Figure 57 : Europe Peptide Therapeutics Market Attractiveness Analysis, by Country, 2022–2031
  • Figure 58 : Europe Peptide Therapeutics Market Attractiveness Analysis, by Route of Administration, 2022–2031
  • Figure 59 : Europe Peptide Therapeutics Market Attractiveness Analysis, by Type, 2022–2031
  • Figure 60 : Europe Peptide Therapeutics Market Attractiveness Analysis, by Technology, 2022–2031
  • Figure 61 : Japan Peptide Therapeutics Market Size (US$ Mn) Forecast, 2021–2031
  • Figure 62 : China Peptide Therapeutics Market Size (US$ Mn) Forecast, 2021–2031
  • Figure 63 : India Peptide Therapeutics Market Size (US$ Mn) Forecast, 2021–2031
  • Figure 64 : Rest of APAC Peptide Therapeutics Market Size (US$ Mn) Forecast, 2021–2031
  • Figure 65 : Asia Pacific Peptide Therapeutics Market Attractiveness Analysis, by Country/Sub-region, 2022–2031
  • Figure 66 : Asia Pacific Peptide Therapeutics Market Attractiveness Analysis, by Route of Administration, 2022–2031
  • Figure 67 : Asia Pacific Peptide Therapeutics Market Attractiveness Analysis, by Type, 2022–2031
  • Figure 68 : Asia Pacific Peptide Therapeutics Market Attractiveness Analysis, by Technology, 2022–2031
  • Figure 69 : Brazil Peptide Therapeutics Market Size (US$ Mn) Forecast, 2021–2031
  • Figure 70 : Mexico Peptide Therapeutics Market Size (US$ Mn) Forecast, 2021–2031
  • Figure 71 : Rest of LATAM Peptide Therapeutics Market Size (US$ Mn) Forecast, 2021–2031
  • Figure 72 : Latin America Peptide Therapeutics Market Attractiveness Analysis, by Country/Sub-region, 2022–2031
  • Figure 73 : Latin America Peptide Therapeutics Market Attractiveness Analysis, by Route of Administration, 2022–2031
  • Figure 74 : Latin America Peptide Therapeutics Market Attractiveness Analysis, by Type, 2022–2031
  • Figure 75 : Latin America Peptide Therapeutics Market Attractiveness Analysis, by Technology, 2022–2031
  • Figure 76 : South Africa Peptide Therapeutics Market Size (US$ Mn) Forecast, 2021–2031
  • Figure 77 : Saudi Arabia Peptide Therapeutics Market Size (US$ Mn) Forecast, 2021–2031
  • Figure 78 : Rest of MEA Peptide Therapeutics Market Size (US$ Mn) Forecast, 2021–2031
  • Figure 79 : Middle East & Africa Peptide Therapeutics Market Attractiveness Analysis, by Country/Sub-region, 2022–2031
  • Figure 80 : Middle East & Africa Peptide Therapeutics Market Attractiveness Analysis, by Route of Administration, 2022–2031
  • Figure 81 : Middle East & Africa Peptide Therapeutics Market Attractiveness Analysis, by Type, 2022–2031
  • Figure 82 : Middle East & Africa Peptide Therapeutics Market Attractiveness Analysis, by Technology, 2022–2031
  • Figure 83 : Peptide Therapeutics Market Share Analysis, by Company, 2021

Leaders in analytics, research and advisory services for Fortune 500 companies, scores of high potential startups, and financial institutions. Our success stories have proven why we are a prominent provider of a cutting-edge syndicated and customized research services. Leverage the best of our seasoned research analysts who had a keen interest and enviable expertise of almost 4 million hours in global, regional, and local market intelligence.

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More
Peptide Therapeutics Market (Application: Cancer, Metabolic, CVD, Respiratory, GIT, Anti-infective, Dermatology, CNS, and Renal) - Global Industry Analysis,...